What changed in Cvs Health Corporation's latest annual report
In the year ended 31 Dec 2025, Cvs Health Corporation's revenue rose 7.8% to USD 402.07bn, from USD 372.81bn; net income fell 61.7% to USD 1.77bn, from USD 4.61bn; cash and cash equivalents fell 1.5% to USD 8.45bn, from USD 8.59bn.
Year ended 31 Dec 2025. Source: 10-K filed 10 Feb 2026, read it on SEC EDGAR.
USD 372.81bn to USD 402.07bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 372.81bn | 402.07bn | Up 7.8% |
| Net income | 4.61bn | 1.77bn | Down 61.7% |
| Total assets | 253.22bn | 253.54bn | Up 0.1% |
| Total liabilities | 177.49bn | 178.16bn | Up 0.4% |
| Cash and cash equivalents | 8.59bn | 8.45bn | Down 1.5% |
| Shareholders' equity | 75.56bn | 75.21bn | Down 0.5% |
Questions people ask
Did Cvs Health Corporation's revenue grow last year?
Revenue grew 7.8%, from USD 372.81bn to USD 402.07bn in the year ended 31 Dec 2025.
Is Cvs Health Corporation profitable?
Yes. Net income was USD 1.77bn in the year ended 31 Dec 2025. The year before: USD 4.61bn.
How much cash and debt does Cvs Health Corporation have?
At its latest year end (31 Dec 2025), Cvs Health Corporation reported cash and cash equivalents of USD 8.45bn.
Where do these numbers come from?
From Cvs Health Corporation's own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with Cvs Health Corporation?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demo